Participate in Our Latest Clinical Study Today
- Start date
- Starts Jan 12th
- Therapy area(s)
- Healthy volunteers
- Location
- Las Vegas
- Compensation
- Up to $16425
- Status
-
Enrolling now
Requirements.
Participants must meet the following inclusion criteria to be eligible for this clinical trial:
- Healthy Men
- Ages 18 to 55
- Must not have used nicotine or nicotine-containing products in the 3 months before dose
- BMI: 18 to 32kg/m2
- Health status is further evaluated by reviewing medical history, screening assessments, and visit with physician
About study.
The purpose of this study is to evaluate the safety and tolerability of a single dose of the study drug in healthy adults. The study drug is being developed as a potential treatment against pneumonic plague. Healthy volunteers without pre-exposure to pneumonic plague are needed at this stage of research. This is a research study, and your participation is voluntary. You may stop participating at any time.
Submit request for call back.
You can sign up by calling the clinic’s call center or request a call back here.
Locations
| Location | Start date | Status |
|---|---|---|
| Las Vegas | Jan 12th |
Enrolling now
|



